The expansion of clinical pharmacy capacity across primary care has transformed how general practice manages daily prescribing demands. However, deploying permanent pharmacy staff or temporary locums without structured clinical leadership creates significant administrative and safety challenges for practices.
This is why one of the most common questions we get asked about our service (whether it’s via the website or when we are out and about meeting PCN leaders) is whether we can provide clinical oversight, leadership or governance to their team. We do – clinical oversight is baked into the foundations of our managed service model. Why? In this blog, we’ll take a look at why governance and clinical oversight for your internal teams is crucial, who should be doing it and can new technology (like AI) help.
Key Takeaways
- Clinical pharmacists represent the largest single profession recruited through the Additional Roles Reimbursement Scheme (ARRS).
- Deploying clinical pharmacy capacity without structured supervision shifts heavy administrative and medico-legal burdens back onto overstretched GP partners.
- Internal AI software tools streamline triage and risk profiling, but regulatory guidelines require qualified human clinical governance to verify outputs and assume legal accountability.
- Standalone remote clinical governance provides senior pharmacist supervision, closed-loop incident auditing, and quality assurance for existing internal staff or locums without requiring extra onsite desk space.
What Is Driving the Rapid Growth of Clinical Pharmacy in Primary Care Networks?
The rapid growth is driven primarily by the Additional Roles Reimbursement Scheme (ARRS). According to NHS England statistics, of the 7,940 clinical pharmacists in England, 5671 were funded via ARRS. Add in a further 2,162 pharmacy technicians, and pharmacy roles represent a substantial portion of the total ARRS workforce.
In addition to added numbers, clinical capabilities continue to broaden too. Over 21,800 pharmacists now hold Independent Prescriber annotations, and all newly qualified pharmacists will prescribe from registration starting September 2026. While this expanding scope brings vital clinical capacity to practices, it also creates an unprecedented demand for ongoing clinical supervision.
Who Oversees Practice Pharmacy Teams in Primary Care Networks?
As practices expand their workforce under the Additional Roles Reimbursement Scheme (ARRS), managing these clinicians has introduced unintended supervisory friction.
In many direct-hire arrangements or locum-dependent setups, clinical supervision defaults directly to GP partners by necessity. While an experienced clinical pharmacist delivers immense value, operating without senior pharmacy leadership means GPs spend valuable clinical sessions answering daily prescribing queries, countersigning decisions, and auditing clinical notes. This dynamic counters the primary objective of workforce expansion (which is to reduce GP workload, not increase it).
When a Primary Care Network relies heavily on short-term locums across multiple sites, the lack of centralised supervision causes inconsistent clinical documentation and variable standards in chronic disease management. Without clear supervisory lines, daily clinical queries accumulate.
The Hidden Operational Risk of Unsupervised Pharmacy Staff
Unsupervised pharmacy staff and temporary locums present operational risks by producing inconsistent clinical documentation, missing standardised prescribing safety targets, and increasing daily escalation queries to duty doctors.
Without centralised oversight, practice management lacks direct visibility into clinical output. Practice managers must ensure that every Structured Medication Review meets national standards and high-risk drug monitoring protocols (such as Lithium and methotrexate checks) are rigorously enforced.
When using locums, clinical documentation style and workflow habits vary significantly, which can lead to missed Quality and Outcomes Framework (QOF) targets and systemic safety gaps. Furthermore, regional leaders at the Integrated Care Board level require transparent activity data and clinical assurances that individual practices struggle to compile manually.
Can AI Tools Replace Human Clinical Supervision in Primary Care?
AI software platforms and clinical algorithms are digital decision-support tools designed to streamline workflow and identify high-risk prescribing, but they cannot replace qualified human clinical supervision or assume legal accountability.
Primary care leaders are increasingly turning to digital solutions to streamline pharmacy operations. Practice teams utilise AI triage platforms (such as Anima, Klinik, or eConsult), ambient scribes (such as Heidi or AccuRx), and population health tools (such as BraveAI or Eclipse) to flag missing blood monitoring, polypharmacy cohorts, or urgent prescription requests.
However, NHS guidance and regulatory standards require a “Human-in-the-Loop” approach. An AI algorithm can scan records and highlight potential clinical risks, but it cannot conduct nuanced clinical evaluations or take legal responsibility for patient safety. Without an internal senior pharmacist framework, every anomaly flagged by AI tools routes directly to GP partners, creating a digital bottleneck. Technology enhances efficiency, but robust clinical governance requires qualified clinical leadership.
How Does Remote Clinical Governance Resolve Oversight Capacity?
Remote clinical governance is an external supervisory framework that delivers senior clinical mentorship, continuous auditing, line management, and incident reviews for a practice’s existing internal or locum staff without requiring physical desk space.
Practices do not need to replace their existing staff or clear physical office space to establish high standards of governance. Through a specialised managed pharmacy service, senior clinical leaders provide an overarching governance shield across your current primary care workforce.
Under this framework, Medacy absorbs internal clinical supervision, direction, and risk control under a “Zero Burden Promise”. When internal pharmacists encounter complex clinical scenarios or require prescribing advice, escalations route directly to Medacy Senior Pharmacists rather than interrupting GP partners.
Key features of standalone remote governance include:
- Systemic Risk Management: Incidents are logged in company-wide learning systems (such as RADAR) to drive continuous safety improvements across primary care settings.
- Seamless Tech Integration: Remote clinical supervisors connect securely via Redcentric VPN to work natively within core clinical software (EMIS Web, SystmOne, Vision or Medicus) alongside your existing workflow and AI tools.
- Quality & Performance Visibility: Regular, closed-loop audits monitor consultation quality, high-risk prescribing safety, and target achievements for the local Integrated Care Board.
By wrapping direct hires or locums in a dedicated supervisory framework, primary care leaders eliminate GP supervision fatigue while maintaining exceptional standards of patient care.
Securing Sustainable Governance for Primary Care Workforce Teams
To protect GP partner retention and maintain patient safety, primary care organisations must match workforce growth with dedicated governance structures. Establishing structured clinical leadership ensures that pharmacy teams operate safely, efficiently, and with complete accountability.
To learn how standalone remote clinical governance can protect your workforce and relieve GP workload, contact us to speak to the team today.
